Nociceptin/orphanin FQ (N/OFQ) has been reported to inhibit neurogenic contractions in various tissues, including guinea pig airways. In the present study, we investigated the ability of N/OFQ to affect cholinergic contractions of human bronchi elicited by electrical field stimulation (EFS). Tissues were obtained from 23 patients undergoing surgery for lung cancer. EFS (20 Hz, 320 mA, 1.5 ms, 10 s) was applied five times every 20 min. Contractions induced by EFS were abolished by either TTX (1 M) or atropine (1 M) and concentration-dependently (10 nM-1 M) inhibited by N/OFQ (Emax, 11.5±1.8% inhibition). The inhibitory effects of N/OFQ were mimicked by the N/OFQ receptor (NOP) ligand [Arg14, Lys15]N/OFQ which displayed however, higher significant maximal effects (17.7±2.9% inhibition, P < 0.05). The actions of N/OFQ and [Arg14, Lys15]N/OFQ were not affected by naloxone (1 M) while prevented by the selective NOP receptor antagonist UFP-101 (10 M). Moreover, the inhibitory effects of NOP agonists were no longer evident in tissues treated with tertiapin (10 M), an inhibitor of inward-rectifier potassium channels. In conclusion, the present data demonstrate that N/OFQ inhibited acetylcholine (ACh) release in the human bronchi via NOP receptor activation. This effect may involve stimulation of potassium currents.

Nociceptin/orphanin FQ inhibits electrically induced contractions of the human bronchus via NOP receptor activation

CALO', Girolamo;GUERRINI, Remo;REGOLI, Domenico;
2005

Abstract

Nociceptin/orphanin FQ (N/OFQ) has been reported to inhibit neurogenic contractions in various tissues, including guinea pig airways. In the present study, we investigated the ability of N/OFQ to affect cholinergic contractions of human bronchi elicited by electrical field stimulation (EFS). Tissues were obtained from 23 patients undergoing surgery for lung cancer. EFS (20 Hz, 320 mA, 1.5 ms, 10 s) was applied five times every 20 min. Contractions induced by EFS were abolished by either TTX (1 M) or atropine (1 M) and concentration-dependently (10 nM-1 M) inhibited by N/OFQ (Emax, 11.5±1.8% inhibition). The inhibitory effects of N/OFQ were mimicked by the N/OFQ receptor (NOP) ligand [Arg14, Lys15]N/OFQ which displayed however, higher significant maximal effects (17.7±2.9% inhibition, P < 0.05). The actions of N/OFQ and [Arg14, Lys15]N/OFQ were not affected by naloxone (1 M) while prevented by the selective NOP receptor antagonist UFP-101 (10 M). Moreover, the inhibitory effects of NOP agonists were no longer evident in tissues treated with tertiapin (10 M), an inhibitor of inward-rectifier potassium channels. In conclusion, the present data demonstrate that N/OFQ inhibited acetylcholine (ACh) release in the human bronchi via NOP receptor activation. This effect may involve stimulation of potassium currents.
2005
Basso, M; Risse, Pa; Naline, E; Calo', Girolamo; Guerrini, Remo; Regoli, Domenico; Advenier, C.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/470770
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact